Longitudinal analysis of antibody decay in convalescent COVID-19 patients.

Longitudinal analysis of antibody decay in convalescent COVID-19 patients.
复制标题

DOI:
10.1038/s41598-021-96171-4
复制
发表时间:
2021-08-18
期刊:
影响因子:
4.6
通讯作者:
Chiklis GR
Chiklis GR
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Xia W;Li M;Wang Y;Kazis LE;Berlo K;Melikechi N;Chiklis GR

文献摘要

参考文献

被引文献

相似文献

Determining the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). To quantify the antibody decay rates among the varying levels of anti-nucleocapsid (anti-N) Immunoglobulin G (IgG) in convalescent COVID-19 patients and estimate the length of time they maintained SARS-CoV-2 specific antibodies, we have collected longitudinal blood samples from 943 patients over the course of seven months after their initial detection of SARS-CoV-2 virus by RT-PCR. Anti-N IgG levels were then quantified in these blood samples. The primary study outcome was the comparison of antibody decay rates from convalescent patients with high or low initial levels of antibodies using a mixed linear model. Additional measures include the length of time that patients maintain sustainable levels of anti-N IgG. Antibody quantification of blood samples donated by the same subject multiple times shows a gradual decrease of IgG levels to the cutoff index level of 1.4 signal/cut-off (S/C) on the Abbott Architect SARS-CoV-2 IgG test. In addition, this study shows that antibody reduction rate is dependent on initial IgG levels, and patients with initial IgG levels above 3 S/C show a significant 1.68-fold faster reduction rate compared to those with initial IgG levels below 3 S/C. For a majority of the donors naturally occurring anti-N antibodies were detected above the threshold for only four months after infection with SARS-CoV-2. This study is clinically important for the prediction of immune response capacity in COVID-19 patients.
DOI: 10.1016/j.cell.2021.01.007
发表时间: 2021-02-18
期刊: Cell
影响因子: 64.5
作者:
Sette A;Crotty S
通讯作者: Crotty S
DOI: 10.1038/s41591-020-0897-1
发表时间: 2020-04-29
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Long, Quan-Xin;Liu, Bai-Zhong;Huang, Ai-Long
通讯作者: Huang, Ai-Long
DOI: 10.1016/j.immuni.2020.06.024
发表时间: 2020-08-18
期刊: IMMUNITY
影响因子: 32.4
作者:
Schultheiss, Christoph;Paschold, Lisa;Binder, Mascha
通讯作者: Binder, Mascha
DOI: 10.1126/sciimmunol.abe5511
发表时间: 2020-10-08
期刊: Science immunology
影响因子: 24.8
作者:
Isho B;Abe KT;Zuo M;Jamal AJ;Rathod B;Wang JH;Li Z;Chao G;Rojas OL;Bang YM;Pu A;Christie-Holmes N;Gervais C;Ceccarelli D;Samavarchi-Tehrani P;Guvenc F;Budylowski P;Li A;Paterson A;Yue FY;Marin LM;Caldwell L;Wrana JL;Colwill K;Sicheri F;Mubareka S;Gray-Owen SD;Drews SJ;Siqueira WL;Barrios-Rodiles M;Ostrowski M;Rini JM;Durocher Y;McGeer AJ;Gommerman JL;Gingras AC
通讯作者: Gingras AC
DOI: 10.1016/j.cell.2020.09.038
发表时间: 2020-11-12
期刊: CELL
影响因子: 64.5
作者:
Moderbacher, Carolyn Rydyznski;Ramirez, Sydney, I;Crotty, Shane
通讯作者: Crotty, Shane